Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

This is the logo of the provider
Barcelona Spain 27 - 30 May 2026

European Association for the Study of the Liver (EASL 2026)

Presentation schedule and materials
Wednesday, 27 May 2026
08:30  - 17:00
CEST
WED-190
POSTER
ACT on MASH: A multicountry survey of awareness, understanding, and perceptions of MASLD and MASH, and their relation to cardiometabolic comorbidities, among people with MASLD/MASH or at risk for MASH
Sahar Saeed, PhD1; Husam Albarmawi, PhD2; Edwige-Ludiwyne Balzac, PhD3; Julio Burman4; Nathalie Eklöf, MD5; Takumi Kawaguchi, MD, PhD6; Nobuyoshi Kosaka, PhD7; Jeff McIntyre, MA8; Lauren D. Nephew, MD9; Arash Pakseresht, MD10; Jörn M. Schattenberg, MD11; Cyrielle Caussy, MD, PhD12,13
MATERIALS AVAILABLE
Poster
08:30  - 17:00
CEST
WED-072
POSTER
ACT on MASH: A multicountry online survey of awareness, understanding, and perceptions of MASLD/MASH and cardiometabolic associations among healthcare professionals
Cyrielle Caussy, MD, PhD1,2; Husam Albarmawi, PhD3; Edwige-Ludiwyne Balzac, PhD4; Julio Burman5; Nathalie Eklöf, MD6; Takumi Kawaguchi, MD, PhD7; Nobuyoshi Kosaka, PhD8; Jeff McIntyre, MA9; Lauren D. Nephew, MD10; Arash Pakseresht, MD11; Sahar Saeed, PhD12; Jörn M. Schattenberg, MD13
MATERIALS AVAILABLE
Poster
Thursday, 28 May 2026
12:45  - 13:45
CEST
Symposium
Rethinking MASH: Time to explore a multisystem treatment approach
Aleksander Krag Meena B. Bansal Kirsi Pietiläinen Pam R. Taub
MATERIALS AVAILABLE
Teaser Video
Teaser Video
Summary of the symposium
Summary of the symposium
Summary of the symposium
Friday, 29 May 2026
08:30  - 17:00
CEST
FRI-181
POSTER
Efficacy and safety of semaglutide 2.4 mg in the Japanese subgroup of the ESSENCE study
Atsushi Nakajima1,2; Takeshi Okanoue3; Yoichi Hiasa4; Hirokazu Takahashi5; Adel Belloum6*; Nobuyoshi Kosaka7; Tomoyuki Nishida7; Arun J. Sanyal8
MATERIALS AVAILABLE
Poster
08:30  - 17:00
CEST
POSTER
Semaglutide Shows Favourable Safety Across Subgroups and a Positive Hepatic Safety Profile: Findings from ESSENCE Part 1
Philip N. Newsome1,2; Michael Roden3-5; Igor Bakulin6; Burak Demirel7;  Christina Egebjerg7; Anja Geerts8;George Boon Bee Goh9; Laura Ladrón de Guevara10; Mette Skalshøi Kjaer7; Tomáš Koller11; Heidi Ranndal7; Jörn M. Schattenberg12-14; Elisabetta Bugianesi15; Mary E. Rinella16
MATERIALS AVAILABLE
Poster
08:30  - 17:00
CEST
POSTER
Semaglutide Provides Liver Health-Related Benefits in Menopausal Women Living with MASH:  A Post Hoc Analysis of the ESSENCE Trial Part 1
Manal F. Abdelmalek1; Maria Teresa Arias-Loste2;  Burak Demire3; Gema Fruhbeck4;  Anja Geerts5;  Lise Lotte Gluud6;Laura Ladron de Guevara7;  Ewa Janczewska8; Ole Kleist; Jeppesen3;  Claudia Oliviera9;  Mary E. Rinella10;  Giada Sebastiani11;  Anca Trifan12; Thea Vestergaard3; Elisabetta Bugianesi13
MATERIALS AVAILABLE
Slide
Poster
16:15  - 16:45
CEST
Symposium
FGF21 analogues: From pathways to clinical implications
Mazen Noureddin Mary E. Rinella
MATERIALS AVAILABLE
Teaser Video
Teaser Video
Summary of the meet-the-experts session
Summary of the meet-the-experts session
Summary of the meet-the-experts session
Keywords
MASH
EASL